Most Recent
Copyright Tribunal overstepped with amended Foxtel licence, says Full Court
The Copyright Tribunal erred by including rights in a reissued Foxtel licence agreement that fell outside the authority of the licence grant holder, the Phonographic Performance Company of Australia, the Full Federal Court has found.
Bayer faces appeals of IP Australia rulings on antiseptic patent
Veterinary pharmaceutical companies Norbrook Laboratories and Merial have launched twin appeals of two IP Australia decisions allowing Bayer to amend a proposed patent for a treatment for mammary gland infections.
Motorola accuses Hytera of ‘industrial espionage on a grand scale’
Motorola has slammed Hytera for engaging in “industrial espionage on a grand scale”, after more than a thousand Motorola-branded documents were found in the possession of the Chinese radio maker.
Novartis patent for oral form of top-selling MS drug obvious, IP Australia says
A proposed Novartis patent for an oral form of its top-selling multiple sclerosis drug Gilenya is invalid for lack of inventive step, IP Australia has found, but gave the pharmaceutical giant a chance to amend.
Boehringer hits Teva with counterpunch in inhaler patent battle
German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.
Motorola slams Hytera for ‘unprofessional’ 11th-hour affidavits in long-running IP suit
Motorola has accused rival Hytera Communications of a "deliberate strategy" of filing late affidavits to throw Motorola off in an already highly contentious patent and copyright case over digital radio devices.
Judge slams Fuchs evidence as ‘absolute garbage’ in spat over privileged docs
A judge has panned evidence put on by Fuchs Lubricants in a patent dispute with Quaker Chemical as "woefully inadequate" and "absolutely garbage", partially shooting down the firm's attempt to block discovery of allegedly privileged documents.
Sanofi slams judge’s harm assessment in denying injector pen injunction
A judge that rejected a bid by Sanofi-Aventis for an injunction blocking rival Alphapharm from listing an insulin injector pen on the PBS erred in his consideration of the harm it would face, the drug giant has told the Full Federal Court.
Hytera ordered to hand over ‘stolen’ Motorola code
Hytera Communications has been ordered to hand over source code that Motorola Solutions claims was stolen by three employees who jumped ship between the companies.
Hytera wins bid to postpone Motorola copyright case
Hytera Communications has won its bid to have a new copyright case brought against it by rival Motorola Solutions heard separately from a patent infringement trial scheduled to begin in July next year.